一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Neuropsychiatric Disease and Treatment >>article
Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment

IF: 3.2
Download PDF

Memantine: efficacy and safety in mild-to-severe Alzheimer's disease.

Published:1 April 2007 DOI: 10.2147/nedt.2007.3.2.245 PMID: 19300557
Rajesh R Tampi, Christopher H van Dyck

Abstract

Alzheimer's disease (AD) is the most common cause of dementia, accounting for 25 million cases worldwide. Until recently, the pharmacotherapy of AD was limited to the use of cholinesterase inhibitors (ChEIs) that are approved only for the mild to moderate stages of the illness. Memantine, an NMDA receptor antagonist has been found to be effective, both as monotherapy and in combination with donepezil, in the treatment of patients with moderate to severe stage AD. More recent studies have examined the role of memantine in the treatment of the mild to moderate stages of the disease, although the collective results of these studies remain inconclusive. Available pharmacoeconomic data indicate that treatment with memantine is cost-effective when compared with no treatment in patients with moderate to severe AD. Memantine treatment is predicted to be associated with lower costs of care, longer time to dependence and institutionalization, and gains in quality-adjusted life-years. In this article, we review the evidence for the use of memantine in patients with AD, ranging from the mild to severe stages of disease.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Donepezil 120014-06-4 C24H29NO3 395 suppliers $5.00-$2674.98
Memantine 19982-08-2 C12H21N 211 suppliers $25.00-$1275.12

Similar articles

IF:5.4

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.

ACS Applied Energy Materials María Jesús Friedli, Nibaldo C Inestrosa,etc Published: 29 October 2021
IF:3.5

Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease

Journal of Food Biochemistry Ahsas Goyal, Aanchal Verma,etc Published: 15 September 2022
IF:3.9

Magnesium may be an effective therapy for Alzheimer's disease.

World Journal of Psychiatry Dao-Yun Lei, Jie Sun,etc Published: 19 September 2022
临清市| 镇雄县| 宜良县| 彰化县| 宁武县| 隆化县| 克拉玛依市| 东乌珠穆沁旗| 兖州市| 焦作市| 宜兰市| 合川市| 清徐县| 北流市| 元谋县| 樟树市| 潼关县| 陵川县| 团风县| 驻马店市| 保德县| 三门县| 桐城市| 陆川县| 砚山县| 永昌县| 广河县| 皋兰县| 仁布县| 随州市| 马鞍山市| 铜陵市| 广灵县| 昭苏县| 射洪县| 平顶山市| 牙克石市| 武定县| 西丰县| 洛隆县| 济阳县|